Cytosorbents Corp reports results for the quarter ended in December - Earnings Summary

Cytosorbents

14/03/2024 23:20

* Cytosorbents Corp  CTSO.OQ  reported a quarterly adjusted
loss
of 13 cents​​ per share for the quarter ended in December, lower
than the same quarter last year, when the company reported EPS
of -2 cents.  The mean expectation of four analysts for the
quarter was for a loss of 14 cents per share. Wall Street
expected results to range from -22 cents to -8 cents per share.
    * Revenue fell 7.7% to $8.67 million from a year ago;
analysts
expected $9.29 million. 
    * Cytosorbents Corp's reported EPS for the quarter was a
loss
of 13 cents​.
    * The company reported a quarterly loss of $5.83 million.
    * Cytosorbents Corp shares had fallen by 9.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Cytosorbents Corp
is $4.00 
This summary was machine generated from LSEG data March 14 at
11:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.14          -0.13          Beat
 Sep. 30 2023      -0.14          -0.21          Missed
 Jun. 30 2023      -0.11          -0.14          Missed
 Mar. 31 2023      -0.13          -0.17          Missed